Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,463,647 | 1,431,406 | 1,422,808 | 1,335,582 | 1,347,993 |
| Cost of Goods | 602,431 | 540,427 | 544,084 | 514,762 | 527,926 |
| Gross Profit | 861,216 | 890,979 | 878,724 | 820,820 | 820,067 |
| Operating Expenses | 412,939 | 391,596 | 387,148 | 375,045 | 366,453 |
| Operating Income | 448,708 | 499,810 | 491,660 | 446,537 | 454,540 |
| Interest Expense | -20,885 | -12,287 | -7,949 | -8,793 | -5,757 |
| Other Income | 4,570 | -9,785 | -3,461 | -8,537 | -2,243 |
| Pre-tax Income | 474,163 | 502,312 | 496,148 | 446,793 | 458,054 |
| Income Tax | 90,731 | 103,580 | 103,555 | 98,257 | 78,349 |
| Net Income Continuous | 383,432 | 398,732 | 392,593 | 348,536 | 379,705 |
| Net Income | $383,432 | $398,732 | $392,593 | $348,536 | $379,705 |
| EPS Basic Total Ops | 2.66 | 2.74 | 2.69 | 2.38 | 2.59 |
| EPS Basic Continuous Ops | 2.65 | 2.74 | 2.69 | 2.38 | 2.59 |
| EPS Diluted Total Ops | 2.64 | 2.74 | 2.68 | 2.37 | 2.58 |
| EPS Diluted Continuous Ops | 2.64 | 2.74 | 2.68 | 2.37 | 2.58 |
| EPS Diluted Before Non-Recurring Items | 2.95 | 2.86 | 2.81 | 2.55 | 2.55 |
| EBITDA(a) | $503,829 | $568,842 | $553,990 | $504,206 | $528,829 |